通过皮肤表现诊断 Erdheim-Chester 病 BRAF（-）及阿那白滞素治疗反应良好 - Suppr

Suppr

超能文献

Erdheim-Chester disease BRAF (-) Diagnosis through cutaneous manifestations and good response with anakinra treatment.

作者信息

Morón-Ocaña Juan-Manuel, Pérez-Gil Amalia

机构信息

Dermatology, Hospital Universitario Virgen de Valme, Sevilla, Spain.

出版信息

An Bras Dermatol. 2024 Sep-Oct;99(5):745-747. doi: 10.1016/j.abd.2023.02.012. Epub 2024 May 31.

DOI:10.1016/j.abd.2023.02.012

PMID:38824097

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11342970/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccb0/11342970/b4570f96ee3b/gr1.jpg

相似文献

Erdheim-Chester disease BRAF (-) Diagnosis through cutaneous manifestations and good response with anakinra treatment.

An Bras Dermatol. 2024 Sep-Oct;99(5):745-747. doi: 10.1016/j.abd.2023.02.012. Epub 2024 May 31.

Successful treatment of Erdheim-Chester disease by interleukin-1 receptor antagonist protein.

Joint Bone Spine. 2014 Mar;81(2):175-7. doi: 10.1016/j.jbspin.2013.06.013. Epub 2013 Aug 13.

Successful treatment of cutaneous-onset Erdheim-Chester disease with cobimetinib and anakinra.

Clin Exp Dermatol. 2024 Apr 23;49(5):523-525. doi: 10.1093/ced/llae014.

Erdheim-Chester disease with cardiac involvement successfully treated with anakinra.

Int J Cardiol. 2013 Sep 1;167(5):e115-7. doi: 10.1016/j.ijcard.2013.04.057. Epub 2013 May 6.

[Evaluation of five years of treatment of Erdheim-Chester disease with anakinra: case report and overview of literature].

Vnitr Lek. 2016 Fall;62(10):820-832.

Favorable radiological outcome of skeletal Erdheim-Chester disease involvement with anakinra.

Joint Bone Spine. 2013 Mar;80(2):206-7. doi: 10.1016/j.jbspin.2012.07.005. Epub 2012 Sep 19.

Treatment failure by canakinumab in a patient with progressive multisystemic Erdheim-Chester disease refractory to anakinra: successful use of vemurafenib.

Rheumatology (Oxford). 2015 Oct;54(10):1932-4. doi: 10.1093/rheumatology/kev237. Epub 2015 Jul 2.

Treatment of pediatric Erdheim-Chester disease with interleukin-1-targeting drugs.

Arthritis Rheum. 2011 Dec;63(12):4031-2. doi: 10.1002/art.30638.

Coated aorta in Erdheim-Chester disease.

Rheumatology (Oxford). 2021 Feb 1;60(2):986-987. doi: 10.1093/rheumatology/keaa430.

Efficacy of the MEK inhibitor cobimetinib for wild-type BRAF Erdheim-Chester disease.

Br J Haematol. 2018 Jan;180(1):150-153. doi: 10.1111/bjh.14284. Epub 2016 Oct 6.

引用本文的文献

Recent advances in therapeutic strategies of Erdheim-Chester disease.

Naunyn Schmiedebergs Arch Pharmacol. 2025 Jun;398(6):6407-6428. doi: 10.1007/s00210-024-03769-2. Epub 2025 Jan 21.

本文引用的文献

Superior efficacy and similar safety of double dose anakinra in Erdheim-Chester disease after single dose treatment.

Oncoimmunology. 2018 Apr 9;7(8):e1450712. doi: 10.1080/2162402X.2018.1450712. eCollection 2018.

Variability in the efficacy of the IL1 receptor antagonist anakinra for treating Erdheim-Chester disease.

Blood. 2016 Mar 17;127(11):1509-12. doi: 10.1182/blood-2015-09-672667. Epub 2016 Feb 4.

Cutaneous manifestations of Erdheim-Chester disease (ECD): Clinical, pathological, and molecular features in a monocentric series of 40 patients.

J Am Acad Dermatol. 2016 Mar;74(3):513-20. doi: 10.1016/j.jaad.2015.11.007. Epub 2016 Jan 16.

Erdheim-Chester disease: a systematic review.

Crit Rev Oncol Hematol. 2015 Jul;95(1):1-11. doi: 10.1016/j.critrevonc.2015.02.004. Epub 2015 Feb 17.

BRAFV600E mutant protein is expressed in cells of variable maturation in Langerhans cell histiocytosis.

Blood. 2012 Sep 20;120(12):e28-34. doi: 10.1182/blood-2012-06-429597. Epub 2012 Aug 2.

Recurrent BRAF mutations in Langerhans cell histiocytosis.

Blood. 2010 Sep 16;116(11):1919-23. doi: 10.1182/blood-2010-04-279083. Epub 2010 Jun 2.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验